[Using Necrosis Biomarkers for the Early Diagnosis of Myocardial Infarction in Modern Conditions].
The implimentation of reperfusion treatment of acute coronary syndrome marked the problem of timely allocation of patients with high thrombotic risk. One of the key ways to do this is to use modern biomarkers. The review deals with the peculiarities of using for this purpose the definition of troponin, myoglobin and phosphokinase.